Esquizofrenia y delincuenciaanálisis de la jurisprudencia del Tribunal Supremo entre 2008 y 2018

  1. Romero Álvarez, Juan José 1
  2. Molina Martín, Juan de Dios 1
  1. 1 Universidad Francisco de Vitoria
    info

    Universidad Francisco de Vitoria

    Pozuelo de Alarcón, España

    ROR https://ror.org/03ha64j07

Zeitschrift:
Revista Internacional Jurídica y Empresarial: RIJE

ISSN: 2531-0054

Datum der Publikation: 2019

Titel der Ausgabe: Sociedad digital

Nummer: 2

Seiten: 81-126

Art: Artikel

DOI: 10.32466/EUFV-R.I.J.E.2019.2.538.81-126 DIALNET GOOGLE SCHOLAR lock_openOpen Access editor

Andere Publikationen in: Revista Internacional Jurídica y Empresarial: RIJE

Zusammenfassung

Violence risk in schizophrenia increases due to factors such as substance abuse, deficiencies in the treatment, social and occupational marginalization or low educational level. Through the analysis of the jurisprudence of the Supreme Court, this investigation attempts to achieve three objectives. In the first place, to recognize the risk factors acknowledged in the scientific literature that appear in the judicial doctrine. Secondly, to ascertain the criteria about the imputability of schizophrenic people. Finally, to analyze the presence of the involuntary outpatient treatment as a non custodial security measure. An interview to Fermín Javier Echarri Casi, magistrate of the National Audience, is also included. Paranoid schizophrenia, substance abuse and deficiencies in the treatment are the most significant risk factors that appear in the analyzed sentences. Also, the criteria about the imputability is based on the impairment of capacities and the causal.

Bibliographische Referenzen

  • American Psychiatric Association (1999). DSM-IV: Diagnostic and statistical manual of mental disorders (4th ed., 9th printing.). Washington: American Psychiatric Association.
  • American Psychiatric Association (2000). Directrices para la práctica clínica en el tratamiento de pacientes con esquizofrenia, en Autoevaluación y actualización en psiquiatría. Esquizofrenia y otros trastornos psicóticos, 1-91.
  • American Psychiatric Association (2013). Highlights of Changes from DSM-IV-TR to DSM-5, en American Psychiatric Publishing 1–19.
  • American Psychiatric Association (2014). Manual diagnóstico y estadístico de los trastornos mentales (DSM-5), 5ª ed, Madrid: Editorial Medica Panamericana.
  • Angermeyer, M.C., Matschinger, H. (1995). Violent attacks on public figures by persons suffering from psychiatric disorders. Their effect on the social distance towards the mentally ill. Eur Arch Psychiatry Clin Neurosci; 245: 159-64.
  • Arbach, K. y Pueyo, A.A., Valoración del riesgo de violencia en enfermos mentales con el HCR-20, en Papeles del Psicólogo, 28 (3): 174–186.
  • Arseneault, L., Cannon, M., Poulton, R., Murray, R., Caspi, A., Moffit, T.E. (2002). Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study, en British Medical Journal, 325: 1212-1213.
  • Arseneault, L., Moffitt, T.E., Caspi, A., Taylor, T.J. y Silva, P.A. (2000). Mental disorders and violence in a total birth cohort: results from the Dunedin Study, en Archives of General Psychiatry, 57: 970–986.
  • Baldwin, P., Browne, D., Scully, P.J. (2005). Epidemiology of first-episode psychosis: Illustrating the challenges across Diagnostic boundaries through the Cavan-Monagan study at 8 years, en Schizophrenia Bulletin, 31 (3): 624-38.
  • Batel, P., Lejoyeux, M. y Ades, J. (1993). Prevalence and severity of alcoholism among schizophrenics: a clinical study. ESBRA 4th Congress; 1993 June 2-5; Ligure, Italy. Pergamon Press, 242.
  • Bourget, D., El-Guebaly, N., Atkinson, M.J. (2002). Assessing and managing violent patients, en Bulletin of Can Psychiatr Association, 34: 25-27.
  • Campbell, J. (1994). Taking issue: putting violence in context, en Hospital and Community Psychiatry, 45: 633.
  • Carrasco, J.J. y Maza, J.M. (2010). Tratado de psiquiatría legal y forense. 4ª Edición. Ed. La Ley Actualidad. Madrid. Código Penal Español. Boletín Oficial del Estado. Última actualización del 14 de diciembre de 2017
  • Corominas, M., Roncero, C., Bruguera, E., Casas, M. (2007). Sistema dopaminérgico y adicciones, en Revista de Neurología, 44 (1): 23-31.
  • Diwan, A., Castine, M., Pomerleau, C.S., Meador-Woodruff, J.H. y Dalack, G.W. (1998). Differential prevalence of cigarette smoking in patients with schizophrenic vs. mood disorders, en Schizophrenia Research, 33: 113-8.
  • Dixon, L., Haas, G., Weiden, P.J., Sweeney, J., Frances, A.J. (1991). Drug abuse in schizophrenic patients: Clinical correlates and reasons for use, en American Journal of Psychiatry, 148: 224-30.
  • Echeburúa, E. y Loinaz, I. (2011). Violencia y trastornos mentales en Violencia y psicología comunitaria. Aspectos psicosociales, clínicos y legales, Comares, Granada., 1–22.
  • Esbec, E. (2005). Violencia y Trastorno mental, en Cuadernos de Derecho Judicial, 8: 57–154.
  • Esbec, E., Echeburúa, E. (2016). Violencia y esquizofrenia: un análisis clínico-forense, en Anuario de psicología jurídica, 26: 70-79
  • Fazel, S. y Danesh, J. (2002). Serious mental disorder in 23000 prisoners: a systematic review of 26 surveys, en The Lancet, 359: 545-550.
  • Fazel, S., Gulati, G., Linsell, L., Geddes, J.R. y Grann, M. (2009) Schizophrenia and Violence: Systematic Review and Meta-Analysis, en PLoS Medicine, 6 (8): e1000120.
  • Goldner, E., Hsu, L., Waraich, P. y Somers, J. (2002). Prevalence and incidence studies of schizophrenic disorders: a systematic review of the literature, en Canadian Journal of Psychiatry. 47 (9): 833-843.
  • Gómez Jara, M. y Gómez Marichalar, N. (2009). Prescripción de medicamentos, en Consultas en psiquiatría legal, 129-138. Barcelona. Atelier
  • Green, A.I. (2005). Schizophrenia and comorbid substance use disorder: effects of antipsychotics, en Journal of Clinical Psychiatry, 66 (Suppl 6): 21-26.
  • Green, A.I. (2006). Treatment of schizophrenia and comorbid substance abuse: pharmacologic approaches, en Journal of Clinical Psychiatry, 67 (Suppl 7): 31-35.
  • Hiday V.A. (1995). The social context of mental illness and violence, en Journal of Health and Social Behavior, 36: 122-137.
  • Hiday, V.A., Swartz, M.S., Swanson, J.W., Borum, R. y Wagner, H. (1999). Criminal victimization of persons with severe mental illness, en Psychiatric Services, 50: 62-68.
  • Ho, A. P., Tsuang, J.W., Liberman, R.P., Wang, R., Wilkins, J.N., Eckman, T.A. y Shaner, A. (1999). Achieving effective treatment of patients with chronic psychotic illness and comorbid substance dependence, en American Journal of Psychiatry, 156 (11): 1765-1770.
  • Horsfall J., Cleary M., Hunt G.E. y Walter G. (2009). Psychosocial treatments for people with co-ocurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence, en Harvard Review of Psychiatry, 17 (1): 24-34.
  • Jerrell, J.M. y Ridgely, M.S. (1995). Comparative effectiveness of three approaches to serving people with severe mental illness and substance use disorders, en Journal of Nervous and Mental Disease, 183 (9): 566-76.
  • Jockers-Scherubl, Wolf, T., Radzei, N., Schalttmann, P., Rentzsch, J., Gómez-Carrillo, A. y Kuhl, K. (2007). Cannabis induces different cognitive changes in schizophrenic patients and in healthy controls, en Progress in NeuroPsychopharmacology and Biological Psychiatry, 31 (5): 1054-1063.
  • Joyal, C.C., Putkonen, A., Paavola, P. y Tiihonen, J. (2004). Characteristics and circumstances of homicidal acts committed by offenders with schizophrenia, en Psychological Medicine, 34 (3): 433-442.
  • Kendler, K.S. y Diehl, S.R. (1995). Schizophrenia: Genetics, en Comprehensive Textbook of Psychiatry, 6ª ed, vol I, 942-957.
  • Kosten, T.A. (1997). Enhanced neurobehavioral effects of cocaine with chronic neuroleptic exposure in rats, en Schizophrenia Bulletin, 23 (2): 203-213.
  • Krystal, J.H., D’Souza, D.C., Madonick, S., Petrakis, I.L. (1999). Toward a rational pharmacotherapy of comorbid substance abuse in schizophrenia patients, en Schizophrenia Research, 35 Suppl: 35-49.
  • Ley de Enjuiciamiento Civil. Boletín Oficial del Estado. Última actualización del 4 de noviembre de 2017.
  • Ley de Enjuiciamiento Criminal. Boletín Oficial del Estado. Última actualización del 6 de octubre de 2015.
  • Lysaker, P.H., Bell, M.D., Bioty, S.M. y Zito, W.S. (1997). Cognitive impairment and substance abuse history as predictors of the temporal stability of negative symptoms in schizophrenia, en Journal of Nervous and Mental Disease, 185 (1): 21-26.
  • McGrath, J., Saha, S., Welham, J., El Saadi, O., MacCauley, C., Chant, D. (2004). A systematic review of the incidence of schizophrenia: the distribution of rates and influence of sex, urbanicity, migrant status and methodology, en BMC Medicine, 2, 13.
  • Molina, J. (2013). Trastornos psicóticos. Esquizofrenia (1): subtipos clínicos, cursos evolutivos y tratamiento, en Tratado de medicina legal y ciencias forenses, Volumen V, Psiquiatría legal y forense.
  • Morera, B., Hueso, V. y Martínez, L. (2001). Conductas violentas y enfermedad mental: predicción y abordaje en pacientes hospitalizados, en Archivos de Psiquiatría, 64 (2): 137-154.
  • Mortensen, P.B., Pederson, C.B., Westergaard, T. (1999). Effects of family history and place and season of birth on the risk of schizophrenia, en N Engl J Med, 340, 603-608.
  • Mueser, K.T., Drake, R.E., Wallach, M.A. (1998). Dual diagnosis: a review of etiological theories, en Addictive Behaviors, 23 (6): 717–734
  • Negrete, J.C. (2010) Introducción, en Szerman, N. et al. (eds.), Patología dual en esquizofrenia. Opciones terapéuticas, 19-24. Barcelona, Editorial Glosa.
  • Niechoff, D. (1999). The biology of violence: how understanding the brain, behavior and environment can break the vicious circle of aggression. New York: Free Press.
  • Noordsy, D.L. y Green, A.I. (2003). Pharmacotherapy for schizophrenia and co-occurring substance use disorders, en Current Psychiatry Reports, 5: 340-346.
  • Pescosolido, B.A., Monahan, J., Link. B.G., Stueve, A. y Kikuzawa, S. (1999). The public’s view of the competence, dangerousness, and need for legal coercion of persons with mental health problems en America Journal Public Health, 89: 1339-45.
  • Potvin, S., Briand, C., Prouteau, A., Bouchard, R., Lipp, O., Lalonde, P.,… Stip, E. (2005). CANTAB explicit memory is less impaired in addicted schizophrenia patients, en Brain and Cognition, 59: 38-42.
  • Potvin, S., Sepehry, A. y Stip E. (2007). Meta-analysis of depressive symptoms in dual-diagnosis schizophrenia, en Australian & New Zealand Journal of Psychiatry, 41: 792–799.
  • Regier, D.A., Framer, M.E., Rae, D.S., Locke, B.Z., Keith, S.J., Judd, L. y Goodwin, F. (1990). Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) Study, en The Journal of the American Medical Association (JAMA), 264: 2511-18.
  • Richardson, M., Craig, T. y Haugland, G. (1985). Treatment patterns of young chronic schizophrenic patients in the era of deinstitutionalizatione, en Psychiatr Quart, 57: 104- 110.
  • Rodríguez, J.M. (1970). Derecho penal español. Parte general. Madrid. UNED.
  • Ruiz-Irondo, M., Salaberría, K., Echeburúa, E. (2013). Análisis y tratamiento psicológico de la esquizofrenia en función de los estadios clínicos, en Actas Españolas de Psiquiatría, 41: 52-59.
  • Saiz, J., de la Vega, D. y Sánchez, P. (2010). Bases Neurobiológicas de la Esquizofrenia, en Cínica y Salud, 21 (3): 235-254.
  • Silvestri, S., Negrete, J.C., Seeman, M., Shammi, C.M. y Seeman, P. (2004). Does nicotine affect D2 receptor upregulation? A case-control study, en Acta Psychiatr Scand, 109 (4): 312-7.
  • Stuart, H. (2003). Violence and mental illness: an overview, en World Psychiatry; 2: 121-124 Swanson, J.W., Swartz, M. y Van Dorn, R. (2006). A National Study of Violent Behavior in Persons With Schizophrenia, en Archives of General Psychiatry, 63: 490-499. Tálamo, A., Centorrino, F., Tondo, L., Dimitri, A., Hennen, J. y Baldessarini, R. (2006). Comorbid substance-use in schizophrenia: relation to positive and negative symptoms, en Schizophrenia Research, 86 (1-3): 251-255.
  • Terradillos, J. (1985). Tratamiento jurídico penal de la enajenación, en AA. VV., Comentarios a la legislación penal. Tomo V: La reforma del Código Penal de 1983, Volumen I, Madrid. Edersa
  • Tiihonen, J., Isohanni, M., Räsänen, P., Koiranen, M. y Moring, J. (1997). Specific major mental disorders and criminality: A 26-year prospective study of the 1966 northern Finland birth cohort, en The American Journal of Psychiatry, 154 (6): 840-845.
  • Torre J., de la (1999). La responsabilidad penal en las psicopatologías: valoraciones judiciales y jurisprudenciales, en Estudios de Psicología, 63-64: 163-173.
  • Wessely, S. (1997). The epidemiology of crime, violence and schizophrenia, en British Journal of Psychiatry, 170 (Suppl. 32): 8-11.
  • Xie, H., McHugo, G.J., Helmstetter, B.S. y Drake, R.E. (2005). Three-year recovery outcomes for long-term patients with co-occurring schizophrenic and substance use disorders, en Schizophrenia Research, 75: 337-48.
Fuente de los datos: Dialnet